Abstract
A 56-year-old male was diagnosed with right lung upper lobe squamous cancer with right hilar and mediastinum lymph node metastasis. After four cycles of neoadjuvant immunochemotherapy, reexamination by computed tomography showed progressive disease of the primary lesion. Then, the patient underwent a right lung upper lobectomy, and hilar and mediastinum lymph node dissection. Surgical pathology showed a partial response to immunochemotherapy. Single-cell RNA sequencing was used to characterize the infiltrating immune cell atlas after neoadjuvant immunochemotherapy; the most common infiltrating immune cell types were cytotoxic CD8+ T cells, monocyte-derived dendritic cells, and macrophages. Imaging mass cytometry revealed a transformation from cold to hot tumor after neoadjuvant immunochemotherapy. In this case study, we are the first to report a case of neoadjuvant immunochemotherapy pseudoprogression, proved by surgical pathology, single-cell RNA sequencing, and imaging mass cytometry. Both single-cell RNA sequencing and imaging mass cytometry revealed an activated immune microenvironment after neoadjuvant immunochemotherapy.
Keywords:
NSCLC; imaging mass cytometry; immunotherapy; pseudoprogression; single-cell RNA-sequencing.
Copyright © 2021 Jia, Zhu, Gao, Sun, Tan, Liu, Guo and Yu.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
CD8-Positive T-Lymphocytes / drug effects*
-
CD8-Positive T-Lymphocytes / immunology
-
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / genetics
-
Carcinoma, Non-Small-Cell Lung / immunology
-
Chemotherapy, Adjuvant
-
Cisplatin / therapeutic use
-
Dendritic Cells / drug effects*
-
Dendritic Cells / immunology
-
Deoxycytidine / analogs & derivatives
-
Deoxycytidine / therapeutic use
-
Gemcitabine
-
Gene Expression Profiling
-
Humans
-
Immune Checkpoint Inhibitors / therapeutic use*
-
Immunohistochemistry
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / immunology
-
Lymph Node Excision
-
Lymphatic Metastasis
-
Lymphocytes, Tumor-Infiltrating / drug effects*
-
Lymphocytes, Tumor-Infiltrating / immunology
-
Male
-
Middle Aged
-
Neoadjuvant Therapy*
-
Pneumonectomy
-
RNA-Seq
-
Transcriptome
-
Treatment Outcome
-
Tumor Burden / drug effects
-
Tumor Microenvironment
-
Tumor-Associated Macrophages / drug effects*
-
Tumor-Associated Macrophages / immunology
Substances
-
Antibodies, Monoclonal, Humanized
-
Immune Checkpoint Inhibitors
-
Deoxycytidine
-
sintilimab
-
Cisplatin
-
Gemcitabine